Literature DB >> 32057146

Microglial responses after phagocytosis: Escherichia coli bioparticles, but not cell debris or amyloid beta, induce matrix metalloproteinase-9 secretion in cultured rat primary microglial cells.

Gen Hamanaka1,2, Tomoya Kubo1,2, Ryo Ohtomo1,2, Hajime Takase1,2, Estefania Reyes-Bricio1,2, Shuntaro Oribe3, Noriko Osumi3, Josephine Lok1,2,4, Eng H Lo1,2, Ken Arai1,2.   

Abstract

Upon infection or brain damage, microglia are activated to play roles in immune responses, including phagocytosis and soluble factor release. However, little is known whether the event of phagocytosis could be a trigger for releasing soluble factors from microglia. In this study, we tested if microglia secrete a neurovascular mediator matrix metalloproteinase-9 (MMP-9) after phagocytosis in vitro. Primary microglial cultures were prepared from neonatal rat brains. Cultured microglia phagocytosed Escherichia coli bioparticles within 2 hr after incubation and started to secrete MMP-9 at around 12 hr after the phagocytosis. A TLR4 inhibitor TAK242 suppressed the E. coli-bioparticle-induced MMP-9 secretion. However, TAK242 did not change the engulfment of E. coli bioparticles in microglial cultures. Because lipopolysaccharides (LPS), the major component of the outer membrane of E. coli, also induced MMP-9 secretion in a dose-response manner and because the response was inhibited by TAK242 treatment, we assumed that the LPS-TLR4 pathway, which was activated by adhering to the substance, but not through the engulfing process of phagocytosis, would play a role in releasing MMP-9 from microglia after E. coli bioparticle treatment. To support the finding that the engulfing step would not be a critical trigger for MMP-9 secretion after the event of phagocytosis in microglia, we confirmed that cell debris and amyloid beta were both captured into microglia via phagocytosis, but neither of them induced MMP-9 secretion from microglia. Taken together, these data demonstrate that microglial response in MMP-9 secretion after phagocytosis differs depending on the types of particles/substances that microglia encountered.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990Escherichia coli; amyloid beta; cell debris; matrix metalloproteinase-9; microglia; phagocytosis

Year:  2020        PMID: 32057146      PMCID: PMC7256913          DOI: 10.1002/glia.23791

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  58 in total

1.  An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells.

Authors:  Ken Arai; Eng H Lo
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

2.  p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes.

Authors:  Yoko Takahashi; Takakuni Maki; Anna C Liang; Kanako Itoh; Josephine Lok; Noriko Osumi; Ken Arai
Journal:  Brain Res       Date:  2014-10-22       Impact factor: 3.252

Review 3.  Microglia and neuroprotection.

Authors:  Zhihong Chen; Bruce D Trapp
Journal:  J Neurochem       Date:  2015-03-10       Impact factor: 5.372

Review 4.  Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE.

Authors:  M E Smith
Journal:  Microsc Res Tech       Date:  2001-07-15       Impact factor: 2.769

Review 5.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.

Authors:  Yu Tang; Weidong Le
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

6.  Production of interferon-gamma by microglia.

Authors:  J Kawanokuchi; T Mizuno; H Takeuchi; H Kato; J Wang; N Mitsuma; A Suzumura
Journal:  Mult Scler       Date:  2006-10       Impact factor: 6.312

7.  Scavenging of Alzheimer's amyloid beta-protein by microglia in culture.

Authors:  M D Ard; G M Cole; J Wei; A P Mehrle; J D Fratkin
Journal:  J Neurosci Res       Date:  1996-01-15       Impact factor: 4.164

8.  Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture.

Authors:  P E Gottschall; X Yu; B Bing
Journal:  J Neurosci Res       Date:  1995-10-15       Impact factor: 4.164

Review 9.  Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; M Delwar Hussain; Liang-Jun Yan
Journal:  Int J Neurosci       Date:  2013-09-12       Impact factor: 2.292

Review 10.  Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases.

Authors:  Takakuni Maki; Kazuhide Hayakawa; Loc-Duyen D Pham; Changhong Xing; Eng H Lo; Ken Arai
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

View more
  3 in total

1.  Intestinal Barrier Dysfunction Exacerbates Neuroinflammation via the TLR4 Pathway in Mice With Heart Failure.

Authors:  Jun-Yu Huo; Wan-Ying Jiang; Ting Yin; Hai Xu; Yi-Ting Lyu; Yuan-Yuan Chen; Meng Chen; Jie Geng; Zhi-Xin Jiang; Qi-Jun Shan
Journal:  Front Physiol       Date:  2021-08-06       Impact factor: 4.566

2.  Microglia subtypes show substrate- and time-dependent phagocytosis preferences and phenotype plasticity.

Authors:  Shuailong Li; Isa Wernersbach; Gregory S Harms; Michael K E Schäfer
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

3.  Selenium Nanoparticles-Enriched Lactobacillus casei ATCC 393 Prevents Cognitive Dysfunction in Mice Through Modulating Microbiota-Gut-Brain Axis.

Authors:  Lei Qiao; Yue Chen; Xiaofan Song; Xina Dou; Chunlan Xu
Journal:  Int J Nanomedicine       Date:  2022-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.